View Financial HealthXinjiang Xuefeng Sci-Tech(Group)Co.Ltd 配当と自社株買い配当金 基準チェック /36Xinjiang Xuefeng Sci-Tech(Group)Co.Ltd配当を支払う会社であり、現在の利回りは1.71%で、収益によって十分にカバーされています。主要情報1.7%配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長14.3%次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向33%最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesBoard Change • May 20Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). Employee Representative Supervisor Jing Li is the most experienced director on the board, commencing their role in 2021. Independent Director Jin Hong Han was the last independent director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.お知らせ • Mar 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q1, 2026 Results on Apr 17, 2026Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q1, 2026 results on Apr 17, 2026お知らせ • Mar 19Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Apr 09, 2026Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Apr 09, 2026, at 15:30 China Standard Time. Location: The Company's Meeting Room, Urumqi, Xinjiang Chinaお知らせ • Dec 26Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Fiscal Year 2025 Results on Mar 20, 2026Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report fiscal year 2025 results on Mar 20, 2026お知らせ • Sep 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q3, 2025 Results on Oct 21, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q3, 2025 results on Oct 21, 2025お知らせ • Jun 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report First Half, 2025 Results on Aug 15, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report first half, 2025 results on Aug 15, 2025お知らせ • Apr 17Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, May 08, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, May 08, 2025, at 15:00 China Standard Time. Location: The Company's Meeting Room, Urumqi, Xinjiang Chinaお知らせ • Mar 28Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q1, 2025 Results on Apr 25, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q1, 2025 results on Apr 25, 2025お知らせ • Feb 27Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) Completed the acquisition of 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd.Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) entered into Equity Transfer Framework Agreement to acquire 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd. for CNY 2.2 billion on July 2, 2024. Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) signed the share purchase Agreement to acquire 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd. for CNY 2.2 billion on December 11, 2024. A cash consideration valued at CNY 9.8 per share will be paid by Guangdong Hongda Holdings for 225,055,465 shares. The transaction is subject to approval or confirmation of the state-owned assets supervision and administration department, the State Administration for Market Regulation, the Shanghai Stock Exchange and other relevant competent authorities, and the application for share transfer registration through the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. As of December 11, 2024, the deal is subject to approval by the shareholders of Xinjiang Xuefeng Sci Tech(Group)Co.,Ltd and Guangdong Provincial State-owned Assets Supervision and Administration Commission. The acquisition has been approved by the Board of Directors of Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd and Xinjiang State-owned Assets Supervision and Administration Commission. Xia Xiaohui of CITIC Securities Co., Ltd. acted as a financial advisor in the deal while Huang Xiaoli of Jun He Law Offices acted as the legal advisor to Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd. Guangdong Sinong Certified Public Accountants (Special General Partnership) acted as an accountant in the deal. Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) Completed the acquisition of 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd. on February 25, 2025.お知らせ • Dec 27Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Fiscal Year 2024 Results on Apr 17, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report fiscal year 2024 results on Apr 17, 2025Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.22 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.20 (down from CN¥0.22 in 3Q 2023). Revenue: CN¥1.74b (up 1.6% from 3Q 2023). Net income: CN¥210.1m (down 11% from 3Q 2023). Profit margin: 12% (down from 14% in 3Q 2023). The decrease in margin was driven by higher expenses.Buy Or Sell Opportunity • Oct 28Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 31% to CN¥8.55. The fair value is estimated to be CN¥7.10, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 19%.Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥8.37, the stock trades at a trailing P/E ratio of 12.1x. Average trailing P/E is 30x in the Chemicals industry in China. Total returns to shareholders of 6.1% over the past year.お知らせ • Sep 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q3, 2024 Results on Oct 29, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q3, 2024 results on Oct 29, 2024Reported Earnings • Aug 16Second quarter 2024 earnings released: EPS: CN¥0.25 (vs CN¥0.26 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.25 (down from CN¥0.26 in 2Q 2023). Revenue: CN¥1.64b (down 12% from 2Q 2023). Net income: CN¥266.5m (down 2.0% from 2Q 2023). Profit margin: 16% (up from 15% in 2Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China.お知らせ • Jun 28Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report First Half, 2024 Results on Aug 16, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report first half, 2024 results on Aug 16, 2024お知らせ • Jun 06Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Jun 25, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Jun 25, 2024, at 10:30 China Standard Time. Location: The Company's Meeting Room, Urumqi, Xinjiang ChinaReported Earnings • Apr 30First quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.24 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.12 (down from CN¥0.24 in 1Q 2023). Revenue: CN¥1.18b (down 35% from 1Q 2023). Net income: CN¥125.3m (down 45% from 1Q 2023). Profit margin: 11% (down from 13% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China.Reported Earnings • Apr 12Full year 2023 earnings released: EPS: CN¥0.82 (vs CN¥0.81 in FY 2022)Full year 2023 results: EPS: CN¥0.82 (up from CN¥0.81 in FY 2022). Revenue: CN¥7.02b (up 1.7% from FY 2022). Net income: CN¥853.5m (up 28% from FY 2022). Profit margin: 12% (up from 9.6% in FY 2022). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China.お知らせ • Mar 29Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q1, 2024 results on Apr 30, 2024Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥5.63, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry in China.お知らせ • Dec 29Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Fiscal Year 2023 Results on Apr 11, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report fiscal year 2023 results on Apr 11, 2024Reported Earnings • Oct 21Third quarter 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.21 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.22 (up from CN¥0.21 in 3Q 2022). Revenue: CN¥1.71b (up 49% from 3Q 2022). Net income: CN¥236.0m (up 59% from 3Q 2022). Profit margin: 14% (in line with 3Q 2022).お知らせ • Sep 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q3, 2023 Results on Oct 27, 2023Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q3, 2023 results on Oct 27, 2023Reported Earnings • Aug 18Second quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.20 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.26 (up from CN¥0.20 in 2Q 2022). Revenue: CN¥1.85b (up 79% from 2Q 2022). Net income: CN¥271.9m (up 85% from 2Q 2022). Profit margin: 15% (in line with 2Q 2022).お知らせ • Jun 28Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report First Half, 2023 Results on Aug 18, 2023Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report first half, 2023 results on Aug 18, 2023Valuation Update With 7 Day Price Move • May 08Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥10.22, the stock trades at a trailing P/E ratio of 15x. Average trailing P/E is 29x in the Chemicals industry in China.Reported Earnings • Apr 28Full year 2022 earnings released: EPS: CN¥0.81 (vs CN¥0.20 in FY 2021)Full year 2022 results: EPS: CN¥0.81 (up from CN¥0.20 in FY 2021). Revenue: CN¥6.90b (up 165% from FY 2021). Net income: CN¥665.8m (up 356% from FY 2021). Profit margin: 9.6% (up from 5.6% in FY 2021). The increase in margin was driven by higher revenue.Board Change • Mar 15Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 8 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Independent Director Zu Yi Yang was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.決済の安定と成長配当データの取得安定した配当: 603227の配当金支払いは、過去10年間 変動性 が高かった。増加する配当: 603227の配当金は過去10年間にわたって増加しています。配当利回り対市場Xinjiang Xuefeng Sci-Tech(Group)Co.Ltd 配当利回り対市場603227 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (603227)1.7%市場下位25% (CN)0.4%市場トップ25% (CN)1.9%業界平均 (Chemicals)1.3%アナリスト予想 (603227) (最長3年)n/a注目すべき配当: 603227の配当金 ( 1.71% ) はCN市場の配当金支払者の下位 25% ( 0.36% ) よりも高くなっています。高配当: 603227の配当金 ( 1.71% ) はCN市場の配当金支払者の上位 25% ( 1.95% ) と比較すると低いです。株主への利益配当収益カバレッジ: 603227の 配当性向 ( 33.1% ) はかなり低いため、配当金の支払いは利益によって十分にカバーされます。株主配当金キャッシュフローカバレッジ: 603227は配当金を支払っていますが、同社にはフリーキャッシュフローがありません。高配当企業の発掘7D1Y7D1Y7D1YCN 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/26 03:37終値2026/05/26 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Huaichao ZhuangHaitong International Research Limited
Board Change • May 20Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). Employee Representative Supervisor Jing Li is the most experienced director on the board, commencing their role in 2021. Independent Director Jin Hong Han was the last independent director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
お知らせ • Mar 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q1, 2026 Results on Apr 17, 2026Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q1, 2026 results on Apr 17, 2026
お知らせ • Mar 19Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Apr 09, 2026Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Apr 09, 2026, at 15:30 China Standard Time. Location: The Company's Meeting Room, Urumqi, Xinjiang China
お知らせ • Dec 26Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Fiscal Year 2025 Results on Mar 20, 2026Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report fiscal year 2025 results on Mar 20, 2026
お知らせ • Sep 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q3, 2025 Results on Oct 21, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q3, 2025 results on Oct 21, 2025
お知らせ • Jun 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report First Half, 2025 Results on Aug 15, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report first half, 2025 results on Aug 15, 2025
お知らせ • Apr 17Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, May 08, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, May 08, 2025, at 15:00 China Standard Time. Location: The Company's Meeting Room, Urumqi, Xinjiang China
お知らせ • Mar 28Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q1, 2025 Results on Apr 25, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q1, 2025 results on Apr 25, 2025
お知らせ • Feb 27Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) Completed the acquisition of 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd.Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) entered into Equity Transfer Framework Agreement to acquire 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd. for CNY 2.2 billion on July 2, 2024. Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) signed the share purchase Agreement to acquire 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd. for CNY 2.2 billion on December 11, 2024. A cash consideration valued at CNY 9.8 per share will be paid by Guangdong Hongda Holdings for 225,055,465 shares. The transaction is subject to approval or confirmation of the state-owned assets supervision and administration department, the State Administration for Market Regulation, the Shanghai Stock Exchange and other relevant competent authorities, and the application for share transfer registration through the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. As of December 11, 2024, the deal is subject to approval by the shareholders of Xinjiang Xuefeng Sci Tech(Group)Co.,Ltd and Guangdong Provincial State-owned Assets Supervision and Administration Commission. The acquisition has been approved by the Board of Directors of Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd and Xinjiang State-owned Assets Supervision and Administration Commission. Xia Xiaohui of CITIC Securities Co., Ltd. acted as a financial advisor in the deal while Huang Xiaoli of Jun He Law Offices acted as the legal advisor to Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd. Guangdong Sinong Certified Public Accountants (Special General Partnership) acted as an accountant in the deal. Guangdong Hongda Holdings Group Co., Ltd. (SZSE:002683) Completed the acquisition of 21% stake in Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHSE:603227) from Xinjiang Xuefeng Investment Holding Co., Ltd. on February 25, 2025.
お知らせ • Dec 27Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Fiscal Year 2024 Results on Apr 17, 2025Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report fiscal year 2024 results on Apr 17, 2025
Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.22 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.20 (down from CN¥0.22 in 3Q 2023). Revenue: CN¥1.74b (up 1.6% from 3Q 2023). Net income: CN¥210.1m (down 11% from 3Q 2023). Profit margin: 12% (down from 14% in 3Q 2023). The decrease in margin was driven by higher expenses.
Buy Or Sell Opportunity • Oct 28Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 31% to CN¥8.55. The fair value is estimated to be CN¥7.10, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 19%.
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥8.37, the stock trades at a trailing P/E ratio of 12.1x. Average trailing P/E is 30x in the Chemicals industry in China. Total returns to shareholders of 6.1% over the past year.
お知らせ • Sep 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q3, 2024 Results on Oct 29, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q3, 2024 results on Oct 29, 2024
Reported Earnings • Aug 16Second quarter 2024 earnings released: EPS: CN¥0.25 (vs CN¥0.26 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.25 (down from CN¥0.26 in 2Q 2023). Revenue: CN¥1.64b (down 12% from 2Q 2023). Net income: CN¥266.5m (down 2.0% from 2Q 2023). Profit margin: 16% (up from 15% in 2Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China.
お知らせ • Jun 28Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report First Half, 2024 Results on Aug 16, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report first half, 2024 results on Aug 16, 2024
お知らせ • Jun 06Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Jun 25, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd, Annual General Meeting, Jun 25, 2024, at 10:30 China Standard Time. Location: The Company's Meeting Room, Urumqi, Xinjiang China
Reported Earnings • Apr 30First quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.24 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.12 (down from CN¥0.24 in 1Q 2023). Revenue: CN¥1.18b (down 35% from 1Q 2023). Net income: CN¥125.3m (down 45% from 1Q 2023). Profit margin: 11% (down from 13% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China.
Reported Earnings • Apr 12Full year 2023 earnings released: EPS: CN¥0.82 (vs CN¥0.81 in FY 2022)Full year 2023 results: EPS: CN¥0.82 (up from CN¥0.81 in FY 2022). Revenue: CN¥7.02b (up 1.7% from FY 2022). Net income: CN¥853.5m (up 28% from FY 2022). Profit margin: 12% (up from 9.6% in FY 2022). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China.
お知らせ • Mar 29Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q1, 2024 results on Apr 30, 2024
Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥5.63, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry in China.
お知らせ • Dec 29Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Fiscal Year 2023 Results on Apr 11, 2024Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report fiscal year 2023 results on Apr 11, 2024
Reported Earnings • Oct 21Third quarter 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.21 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.22 (up from CN¥0.21 in 3Q 2022). Revenue: CN¥1.71b (up 49% from 3Q 2022). Net income: CN¥236.0m (up 59% from 3Q 2022). Profit margin: 14% (in line with 3Q 2022).
お知らせ • Sep 30Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report Q3, 2023 Results on Oct 27, 2023Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report Q3, 2023 results on Oct 27, 2023
Reported Earnings • Aug 18Second quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.20 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.26 (up from CN¥0.20 in 2Q 2022). Revenue: CN¥1.85b (up 79% from 2Q 2022). Net income: CN¥271.9m (up 85% from 2Q 2022). Profit margin: 15% (in line with 2Q 2022).
お知らせ • Jun 28Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd to Report First Half, 2023 Results on Aug 18, 2023Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd announced that they will report first half, 2023 results on Aug 18, 2023
Valuation Update With 7 Day Price Move • May 08Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥10.22, the stock trades at a trailing P/E ratio of 15x. Average trailing P/E is 29x in the Chemicals industry in China.
Reported Earnings • Apr 28Full year 2022 earnings released: EPS: CN¥0.81 (vs CN¥0.20 in FY 2021)Full year 2022 results: EPS: CN¥0.81 (up from CN¥0.20 in FY 2021). Revenue: CN¥6.90b (up 165% from FY 2021). Net income: CN¥665.8m (up 356% from FY 2021). Profit margin: 9.6% (up from 5.6% in FY 2021). The increase in margin was driven by higher revenue.
Board Change • Mar 15Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 8 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Independent Director Zu Yi Yang was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.